References
Bechstein WO (2000) Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transpl Int 13:313–326
Wijdicks EFM, Wiesner RH, Dahlke LJ, Krom RAF (1994) FK506 induced neurotoxicity in liver transplantation. Ann Neurol 35:498–501
Eidelmann BH, Abu-Elmagd K, Wilson J, Fung JJ, Alesiani M, Jain A, et al. (1991) Neurologic complications of FK 506. Transplant Proc 23:3175–3178
Schreier SL, Crabtree GR (1992) The mechanism of action of cyclosporin A and FK506. Immunol Today 13:136–142
Casey SO, Sampaio RC, Michel E, Truwit CL (2000) Posterior Reverible Encephalopathy Syndrome: Utility of Fluid-Attenuated Inversion Recovery MR Imagong in the Detection of Cortical and Subcortical Lesions. Am J Neuroradiol 21:1199–1206
Stoltenburg-Didinger G, Boegner F (1992) Glia toxicity in dissociated cell cultures induced by cyclosporine. Neurotoxiologie 13:179–184
Neuhaus P, McMaster P, Calne R (1994) Neurological complications in the European multicentre study of FK506 and Cyclosporin in primary liver transplantation. Transpl Int 7 (Suppl 1):S27–31
Bäckmann L, Nicar M, Levy M, Distant D, Eisenstein C, Renard T, et al. (1994) FK506 trough levels in whole blood and plasma in liver transplant recipients. Correlation with clinical events and side effects. Transplantation 57(4):519–525
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Reinohs, M., Straube, T., Baum, P. et al. Recurrent reversible cerebral edema after long term immunosuppression with tacrolimus. J Neurol 249, 780–781 (2002). https://doi.org/10.1007/s00415-002-0703-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-002-0703-7